Technology Transfer Licensing Opportunities at CHORI

Please click on the linked text for descriptions of each of the available technologies. This page is continuously being updated, however; if a technology in which you are interested is not yet linked to its description, or if you would like more information, please contact us.

Therapeutics

CH-008 Cystic Fibrosis Therapy

CH-009 Modulation of Sphingosine-1-Phosphate

CH-016 & CH-028 Iron Chelation Therapies

CH-032 Therapeutic for Respiratory Diseases

CH-033 Use of Tocopherol as for use as Anti-inflammatory Agent

CH-034 Use of Tocopherol as for use as Anti-Obesity Agent

CH-041 Therapeutic Pharmaceutical Nitrones

CH-049 Therapy for Metal-related Disorders

CH-054 Anti-Aging Drugs for mitochondrial protection

CH-058 Protection against Radiation Damage

CH-068 Flavonoids for Treatment of Diarrhea

CH-069 Delivery of Drugs to Brain Tumors

CH-110 Treatment for Alzheimer’s

CH-113 Post-exposure Therapeutic for Anthrax

CH-114 Oxidation Resistant for Apo. A-1

CH-056 Therapeutic for Wound Scarring

Diagnostics

CH-026 Diagnosis of SLOS Syndrome

CH-027 Compositions for use in SLOS Assay

CH-050 Diagnostic & Prognostic for Sickle Cell Disease

CH-055 Predictor of Response to Leukotriene-Inhibition

CH-059 Drug Target Test for Statin Efficacy

CH-112 Diagnostics for Risk of Atherosclerosis

CH-117 Clinical Assay for PLA2

Devices

CH-042 Devise Measuring Biochemical Materials

CH-046 Infusion Match System to Prevent Errors

CH-047 Flow-Cytometry Based Micronucleus Assay

CH-106 On-line Reservation & Tracking System

CH-107 New and Improved Flow Chamber

Research Reagents

CH-036 Rapid Detection of Bacillus Species

CH-039 Small Molecule Target 3D RNA Structure

CH-051 KIR Receptor Genotyping Assay

CH-063 Epitope Mapping of Chlamydia Antigens

CH-109 Improved ID and Clustering of Bacillus